Hematopoietic stem cells for treatment of chronic inflammatory demyelinating polyneuropathy
The aim of this study is to assess the efficacy of high-dose cyclophosphamide and anti-thymocyte globulin treatment, followed by autologous hematopoietic stem cell transplantation, in blunting the progression of chronic inflammatory demyelinating polyneuropathy (CIPD).
Read More
Product Information for
Hematopoietic stem cells for treatment of chronic inflammatory demyelinating polyneuropathy